Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) which treats inflammatory pain, acute or chronic. Often prescribed over a long period to relieve the pain of osteoarthritis or tendonitis, it would not be without risk to the heart. A Danish study which has just been published in the British medical journal states that taking diclofenac (better known under the brand names of Voltarene or Flector) would double the risk of heart attack.
Pr Morten Schmidt of Aarhus University Hospital, lead author of the study, also notes a link between regular intake of this anti-inflammatory and the onset in patients of cardiovascular disorders such as arrhythmia, the stroke ischemic and heart failure. He therefore recommends turning to other nonsteroidal anti-inflammatory drugs.
The results of this study are based on data collected nationally from 6.3 million adults in Denmark, between 1996 and 2016. In France, diclofenac has been subject to restrictions on use since its re-evaluation in 2013. It is contraindicated in patients with:
- known congestive heart failure
-
ischemic heart disease
peripheral arterial disease
of cerebrovascular disease.
Read also :
Stopping the marketing of the drug Artotec
Withdrawal of valsartan drugs
-1739366311.jpg "Ellie Bloom: “Seeing the size of the hole in my heart, the cardiologist told me that I had a guardian angel”")
